Hints and tips:
Showing results for Givens v. Pfizer Inc
Related Special Reports
...That is problematic given the amount of contested information and conspiracy theories about medicine and health services that is posted online, for example by members of the “anti-vaccine” movement....
...She said if it controlled costs, the $27bn market capitalisation was quite attractive, given it had more than €17bn in cash and cash equivalents....
...Pfizer and BioNTech will dispute Moderna’s ability to withdraw the pledge when it did, given the World Health Organization did not declare the end of the “global health emergency” until March 2023....
...Paxlovid — designed to be given to patients shortly after they test positive for the virus — has been far easier to obtain in the US than in Europe, where access has often been restricted to the elderly...
...“We believe Pfizer is uniquely positioned to help the portfolio [Biohaven] reach its full potential given our leading scale and capabilities,” said Nick Lagunowich, head of internal medicine at Pfizer....
...But, of course, there’s a reason why it’s widely called Shitibank; the sprawling, gormless Citi has for a v v v very long time proven adept at blithely ambling onto various rakes around the world....
...interactions in Paxlovid “if given with the wrong medication”....
...“Blinded” refers to the arm of a clinical trial in which participants are kept in the dark about whether they are being given a placebo. A lawyer for Bhiwapurkar did not reply to requests for comment....
...“The FTC filing a lawsuit to block this deal will dampen M&A enthusiasm across the biotech sector, particularly given the lack of direct portfolio overlap between Amgen and Horizon,” said Matt Phipps, analyst...
...The holdouts had complained that it was not a good use of stretched healthcare budgets, given the fading threat from Covid-19....
...Last week, a verdict was passed down in the case of Walkers Snack Foods Ltd v Commissioners for His Majesty’s Revenue and Customs, with first-tier tribunal judges Anne Fairpo and Sonia Gable ruling against...
...Shares in Pfizer added about 1 per cent on Friday, while Seagen was up about 0.9 per cent....
...Some analysts said a tie-up between Pfizer and Seagen would be unlikely to provoke a negative response from the Federal Trade Commission given there was limited overlap between the companies’ products....
...Most analysts have praised Pfizer’s selection of acquisitions but some say it is moving too slowly on M&A, given that it still needs to buy companies capable of generating an extra $15bn in annual revenues...
...According to European officials, national healthcare systems in Europe are favouring Pfizer’s Paxlovid, another Covid antiviral pill, whose efficacy in reducing death and hospitalisation has been confirmed...
...Other local remedies have received approval, but experts said Paxlovid remained the medical community’s preferred drug given the clinical evidence of its efficacy....
...Given that close to three-quarters of the 224mn vaccine doses administered in Germany were produced by BioNTech in collaboration with Pfizer, the vast majority of the claims are being brought against the...
...The oncology-focused biotech agreed a $43bn deal to be acquired by Pfizer....
...The rest of the country, in particular under-equipped rural areas, have even dimmer hopes of acquiring the drug given the low import volumes....
...“While the bears will point to the massive Comirnaty beat as unsustainable, we’re not yet throwing in the towel given an emerging pipeline and significant balance sheet flexibility,” he said....
...I think a lot of people were anticipating a V-shaped recovery . . . People are now waking up the realisation that volatility is going to be normal going forward.”...
...The Moderna shot is authorised for anyone aged 18 and over, while the BioNTech/Pfizer vaccine can be given to anyone aged 12 or older....
...“Pfizer/BioNTech has not yet fully reviewed the complaint, but we are surprised by the litigation given the Pfizer/BioNTech Covid-19 vaccine was based on BioNTech’s proprietary mRNA technology and developed...
...“Given management’s urgency to transact, we expect more deals over the balance of 2022 and into 2023,” he said. Pfizer declined to comment....
...But he added that another important question was whether the drug works as well against Omicron, given it was mainly studied when the Delta variant was dominant....
International Edition